)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
AEON Biopharma
AEON Biopharma (AEON) investor relations material
AEON Biopharma Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary30 Mar, 2026
Executive summary
Advanced ABP-450 biosimilar program with positive initial comparative analytical results confirming identical amino-acid sequencing and highly similar functional characteristics to BOTOX®.
Received constructive FDA feedback at BPD Type 2a meeting, providing a clear framework for advancing the analytical plan.
Strengthened balance sheet through $6 million PIPE financing and Daewoong note exchange, reducing outstanding debt by over 90%.
Appointed John Bencich as CFO, bringing over 25 years of capital markets and strategic leadership experience.
Financial highlights
Reported net loss of $39.2 million for the year ended December 31, 2025, compared to net income of $42.0 million in 2024.
Cash and cash equivalents were $3.0 million as of December 31, 2025, excluding $4.2 million received in January 2026.
Total assets increased to $5.6 million at year-end 2025 from $3.1 million at year-end 2024.
Total liabilities rose to $60.6 million at year-end 2025 from $31.7 million at year-end 2024.
Stockholders’ deficit widened to $55.0 million at year-end 2025 from $28.6 million at year-end 2024.
Outlook and guidance
Majority of analytical comparability program expected to be completed in 2026.
Plans to request a BPD Type 2b meeting in 2026 to discuss the next phase for ABP-450 biosimilar approval.
Cash position, including PIPE proceeds, expected to fund operations into Q3 2026.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from AEON Biopharma
- ABP-450 targets BOTOX's dominance with a clinically identical, cost-saving biosimilar.AEON
Corporate presentation30 Mar 2026 - Registers 51.3M shares for resale as it seeks U.S. entry for a BOTOX® biosimilar amid going concern risk.AEONRegistration Filing9 Feb 2026
- Shareholders to vote on key financings and equity plan as company seeks biosimilar funding.AEONProxy Filing29 Dec 2025
- Shareholders to vote on key financings and equity plan amid urgent need for new capital.AEONProxy Filing19 Dec 2025
- Raising up to $200M, including $50M ATM, to fund botulinum toxin biosimilar amid financial risk.AEONRegistration Filing16 Dec 2025
- Shareholders to vote on share increase, reverse split, and warrants to support financing flexibility.AEONProxy Filing2 Dec 2025
- Key votes include director elections and auditor ratification, with new board representation for Daewoong.AEONProxy Filing2 Dec 2025
- Key votes on share increase, reverse split, and warrants aim to ensure capital flexibility and compliance.AEONProxy Filing2 Dec 2025
- Quorum for the 2025 Annual Meeting is updated to 33.34% of voting power.AEONProxy Filing2 Dec 2025
Next AEON Biopharma earnings date
Q1 202613 May, 2026
AEON Biopharma
Next AEON Biopharma earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage